Literature DB >> 2456291

Laminin inhibits human keratinocyte migration.

D T Woodley1, P M Bachmann, E J O'Keefe.   

Abstract

A quantitative migration assay for human keratinocytes was developed to assess the influence of extracellular matrix molecules on cell motility independently from their effect on cell proliferation. Fibronectin and collagen types I and IV markedly promoted keratinocyte migration, but albumin, type V collagen, and heparan sulfate proteoglycan had little effect. In contrast, laminin inhibited keratinocyte motility and dramatically reduced type IV collagen-induced migration in a concentration-dependent manner. Laminin was not toxic, since it had no apparent effect on morphology, growth, or ability of cells to be passaged. Laminin, a major component of the lamina lucida, may inhibit motility of keratinocytes in vivo. Absence of contact with laminin, which accompanies wounding, may facilitate motility and healing in the epidermis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456291     DOI: 10.1002/jcp.1041360118

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

1.  Transmembrane collagen XVII, an epithelial adhesion protein, is shed from the cell surface by ADAMs.

Authors:  Claus-Werner Franzke; Kaisa Tasanen; Heike Schäcke; Zhongjun Zhou; Karl Tryggvason; Cornelia Mauch; Paola Zigrino; Susan Sunnarborg; David C Lee; Falk Fahrenholz; Leena Bruckner-Tuderman
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

2.  Degradation of human collagen isoforms by Clostridium collagenase and the effects of degradation products on cell migration.

Authors:  Lei Shi; Ryan Ermis; Anastacia Garcia; Dale Telgenhoff; Duncan Aust
Journal:  Int Wound J       Date:  2010-04       Impact factor: 3.315

3.  Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.

Authors:  Jon Cogan; Jacqueline Weinstein; Xinyi Wang; Yingping Hou; Sabrina Martin; Andrew P South; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2014-07-23       Impact factor: 11.454

4.  Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo.

Authors:  I Juhasz; G F Murphy; H C Yan; M Herlyn; S M Albelda
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

5.  An in vitro examination of an extracellular matrix scaffold for use in wound healing.

Authors:  Denis E Solomon
Journal:  Int J Exp Pathol       Date:  2002-10       Impact factor: 1.925

6.  Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB.

Authors:  Wei Li; Jianhua Fan; Mei Chen; Shengxi Guan; David Sawcer; Gary M Bokoch; David T Woodley
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

7.  Elevated glucose and fatty acid levels impair substance P-induced dermal microvascular endothelial cell migration and proliferation in an agarose gel model system.

Authors:  Qiang Wang; Lara A Muffley; Kyla Hall; Marie Chase; Nicole S Gibran
Journal:  Shock       Date:  2009-11       Impact factor: 3.454

8.  Characterization of molecular mechanisms underlying mutations in dystrophic epidermolysis bullosa using site-directed mutagenesis.

Authors:  David T Woodley; Yingping Hou; Sabrina Martin; Wei Li; Mei Chen
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

9.  Upregulation of chemokine (C-C motif) ligand 20 in adult epidermal keratinocytes in direct current electric fields.

Authors:  Jessica Amber Jennings; Dongquan Chen; Dale S Feldman
Journal:  Arch Dermatol Res       Date:  2009-09-26       Impact factor: 3.017

10.  Participation of the lipoprotein receptor LRP1 in hypoxia-HSP90alpha autocrine signaling to promote keratinocyte migration.

Authors:  David T Woodley; Jianhua Fan; Chieh-Fang Cheng; Yong Li; Mei Chen; Guojun Bu; Wei Li
Journal:  J Cell Sci       Date:  2009-04-21       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.